Searched for
COVOVAX AND CORBEVAX
View: A safe sub-unit protein vaccine will further enhance booster protection against Covid variantsEven when Omicron variants like BF.7 are exhibiting increased capacity for evading immunity, antibody surge from boosters may prevent sever...- SII lowers price of each dose of Covovax jab from Rs 900 to Rs 225India's drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28 last year and in the 12-17 ...
- Covovax now available for children in India: Adar PoonawallaIn a post on Twitter, he said Covovax, which has been developed by Novavax, "is now available for children in India". He further said, "Thi...
- NTAGI likely to review Covid vaccine call for the 5-12 year-olds on May 4Last week, the Standing Technical Sub-Committee of the NTAGI had recommended inclusion of the Serum Institute's Covovax in the national COV...
- Govt panel recommends inclusion of Covovax in national Covid vaccination drive for those aged 12 and aboveThe COVID-19 Working Group has now recommended to the Standing Technical Sub-Committee of the National Technical Advisory Group on Immunisa...
- Novavax says its COVID vaccine gets India authorisation for teensThe authorization is a global first for the age group for the vaccine, which is manufactured and marketed in India by the Serum Institute o...
- Serum Institute seeks Covovax's inclusion in Covid vaccination drive for 12 years and aboveIndia's drug regulator had granted restricted emergency use authorisation to Covovax for the 12 to 17 years age group subject to certain co...
- DCGI's EUA nod to SII's Covovax for 12-17 yrs age group; Poonawalla says younger age groups to follow shortlyIt is the fourth vaccine to receive the regulator's nod for use among those below 18 years.
- Subject Expert Committee okays Covovax for 12-17 year-oldsThe recommendation is yet to be approved by the DCGI. Pune-based SII had last month sought restricted emergency use of Covovax in adolescen...
- India must use more vaccines in drive, allow boosters to those willing: Experts"Data shows that in people who have taken Covishield, the protein vaccine Covovax works better as a booster than another dose of Covishield...
- NTAGI may meet on Friday to review Covovax, CorbevaxBoth SII and Biological E are conducting Phase III trials of their vaccines on children. These could become the next choices of vaccines fo...
- Children aged 12-14 may get more vaccination optionsPeople in the government are hopeful that by the time vaccination starts for this age group, results of clinical trials of Covovax and Corb...
- No plan yet to take two new shots in Centre's vaccination driveThe government had placed an order for Corbevax even before it received emergency use authorisation (EUA). It paid ₹1,500 crore in advance ...
- View: India needs to act fast to avoid flying blind into Omicron and beyondBooster doses will become available in India from January 10. The prioritisation and sequence of administration would be based on completin...
- COVID-19: Corbevax, Covovax, Molnupiravir approved for emergency useUnion Health Minister Mansukh Mandaviya on Tuesday said that the Central Drug Authority CDSCO has approved the Serum Institute of India's C...
- A game-changing pill and two new vaccines will bolster India's fight against Covid variantsThe recommendations have been sent to the Drug Controller General of India (DCGI), which will soon decide on their approval, people in the ...
- Government panel recommends EUA for COVID-19 vaccines Covovax, Corbevax and anti-Covid pill molnupiravirThe SEC on COVID-19 of the CDSCO, which reviewed the emergency use authorisation (EUA) applications of Serum Institute of India (SII) for t...
- Experts panel to review applications of Covovax & Corbevax jabs; Merck's Covid drug todayThe subject experts committee (SEC), a body under India's drug regulator, will meet on Monday to review the applications for granting appro...
- Indian vaccines should be used as boosters without any delay: ExpertsThis comes even as the government's advisory group on Covid-19 is awaiting data from the National Institute of Virology (NIV), Pune before ...
- Biological E gets nod for phase 2/3 clinical trial of its Covid vaccine on children above 5 years, adolescentsThe approval for conducting phase III comparator safety and immunogenicity trial in adults came after the SEC's review of Phase I and II cl...
Load More
